Randall Kaye, VP of Medical Affairs at AVANIR PHARMACEUTICALS (AVNR), bought 2,500 shares at $9.90 ($25K) on 2006-05-26, disclosed to the SEC on 2006-05-26.
Open-market purchase of $25k AVNR by VP of Medical Affairs. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.89 | 50 | $495 | 2.0% |
| 2 | $9.90 | 200 | $2K | 7.8% |
| 3 | $9.90 | 250 | $2K | 9.8% |
| 4 | $10.14 | 2,000 | $20K | 80.4% |
| Total | $10.09 avg | 2,500 | $25K | 100% |
| Filing → |
| LBPH | BUY | 2024-08-13 | $2K | — | Filing → |
| LBPH | SELL | 2024-08-13 | $1.2M | — | Filing → |
| AXSM | BUY | 2015-12-24 | $9K | — | Filing → |